A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
about
Novel systemic therapy against malignant pleural mesothelioma.Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review.Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools.Strategies for Increasing Pancreatic Tumor Immunogenicity.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling
P2860
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@en
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@nl
type
label
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@en
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@nl
prefLabel
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@en
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@nl
P2093
P2860
P356
P1433
P1476
A phase I, pharmacokinetic and ...... ts with advanced solid tumors.
@en
P2093
A Hollebecque
H T Arkenau
J Mazumdar
P2860
P304
P356
10.1093/ANNONC/MDW427
P577
2016-10-11T00:00:00Z